Exact Sciences (NASDAQ: EXAS) rallied nearly 20% on November 20 after Abbott Laboratories (NYSE: ABT) announced a $21 billion all-cash deal to acquire...

Exact Sciences (NASDAQ: EXAS) rallied nearly 20% on November 20 after Abbott Laboratories (NYSE: ABT) announced a $21 billion all-cash deal to acquire...

A new, noninvasive blood-glucose monitoring system may allow people with diabetes to finally ditch their painful finger pricks and under the skin...

The retailer will move its stock listing from the NYSE to Nasdaq.

Originally Published by: Type 1 diabetes reversed in landmark study, paving the way for human studies Popular diabetes drug could block exercise...

A noninvasive method for measuring blood glucose levels, developed at MIT, could save diabetes patients from having to prick their fingers several...

As technology advances in diabetes care with continuous glucose monitors, insulin pumps and AI-driven alerts, another kind of intelligence is proving...

As technology advances in diabetes care with continuous glucose monitors, insulin pumps and AI-driven alerts, another kind of intelligence is proving...

RTX expands its MRO reach with new Emirates and Qatar Airways agreements, boosting long-term support and enhancing airline reliability.

Amgen's nearly 16% surge follows strong Q3 results, raised sales guidance and growing momentum across key drugs and biosimilars.